Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Posted Basic Consolidated EPS Of $-2.9054

0

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) annual basic consolidated EPS was $-2.9054 for the period ended 2015-12-31. The basic consolidated EPS was $-2.9054 for the quarter ended 2015-12-31.

EPS from continuing operations

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)’s basic EPS from continuing operations was $-2.9054 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-2.9054

EPS contribution from parent

From the parent company Intra-Cellular Therapies Inc. (NASDAQ:ITCI) posted basic EPS of $-2.9054 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-2.9054.

Basic net EPS

The Basic net EPS of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) was $-2.91 for the period ended 2015-12-31. The figure stood at $-2.91 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-2.9054. While the figure for the quarter ended 2015-12-31 stood at $-2.9054.

Basic diluted EPS

The diluted EPS from continuing operation of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) stood at $-2.9054 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-2.9054

Net diluted EPS

The Net diluted EPS was $-2.91 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-2.91.

Diluted EPS from parent

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) diluted EPS from the parent company for the fiscal 2015-12-31 was $-2.9054. The figure for the quarter ended 2015-12-31 was $-2.9054

The net basic EPS was $-2.91 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-2.91

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 8 times, 1 visits today)